Intraoperative Protective Mechanical Ventilation in Patients Requiring Emergency Abdominal Surgery
IMPROVE-2
2 other identifiers
interventional
707
1 country
28
Brief Summary
The aim of this study is to compare the effects of a strategy aimed at increasing alveolar recruitment (high PEEP levels adjusted according to driving pressure and recruitment maneuvers) with that of a strategy aimed at minimizing alveolar distension (low PEEP level without recruitment maneuver) on postoperative respiratory failure and mortality in patients receiving low VT ventilation during emergency abdominal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
28 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2019
CompletedFirst Posted
Study publicly available on registry
June 17, 2019
CompletedStudy Start
First participant enrolled
February 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 27, 2022
CompletedApril 21, 2026
April 1, 2026
1.4 years
June 12, 2019
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative respiratory failure
Composite criteria : 1. \- Failure to wean from the ventilator after surgery (Yes or No) 2. \- Requiring unplanned reintubation (Yes or No) 3. \- Curative non-invasive ventilation once extubated postoperatively (Yes or No) 4. \- Death (all cause of mortality) (Yes or No) If at least one of these 4 criteria is answered yes, the composite criterion (i.e. the primary outcome) will be answered yes
Hospital discharge - Up to day 30
Secondary Outcomes (25)
Postoperative pulmonary complications
Day 30
Postoperative extra-pulmonary complications
Day 30
SOFA
Day 1
SOFA
Day 2
SOFA
Day 3
- +20 more secondary outcomes
Study Arms (2)
Low PEEP group
ACTIVE COMPARATORPatients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers
Driving-pressure-guided group
EXPERIMENTALPatients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers
Interventions
Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers.
Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers
Eligibility Criteria
You may qualify if:
- Adult (≥18 years)
- Patients requiring emergency (defined by the need to proceed to surgery within a few hours after diagnosis)
- Laparoscopic or non-laparoscopic abdominal surgery under general anesthesia and with an expected duration of at least two hours
You may not qualify if:
- Patients already receiving mechanical ventilation for more than 12 hours before enrollment
- Intracranial hypertension
- Chronic respiratory disease requiring oxygen therapy or mechanical ventilation at home
- Undrained pneumothorax or subcutaneous emphysema
- Patients for which death is deemed imminent and inevitable or patients with an underlying disease process with a life expectancy of less than 3 month
- Body mass index (BMI) \>40 kg/m2
- Pregnant or breastfeeding women
- Patients already enrolled in the IMPROVE-2 trial
- Participation in a confounding trial with mortality or PRF as the main endpoint
- Patient's or relative's refusal to participate
- Guardianship or trusteeship patient
- No affiliation to the Social Security system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (28)
University hospital
Angers, France
Hospital
Annecy, France
University hospital
Besançon, France
University Hospital
Bordeaux, France
Hospital
Chalon-sur-Saône, France
University hospital
Clermont-Ferrand, France
University hospital
Dijon, France
University hospital
Grenoble, France
University hospital
Le Mans, France
University hospital
Lille, France
University hospital
Lyon, France
University hospital
Marseile, France
Assistance Publique-Hôpitaux de Marseille
Marseille, France
Institut Paoli Calmette
Marseille, France
University hospital
Marseille, France
University hospital
Montpellier, France
University Hospital
Nantes, France
University hospital
Nice, France
University hospital
Nîmes, France
Assistance Publique-Hôpitaux de Paris
Paris, France
Hospital
Périgueux, France
University hospital
Pointe à Pitre, 97159, France
University hospital
Rennes, France
University hospital
Saint-Etienne, France
University hospital
Strasbourg, France
Hospital
Suresnes, France
University hospital
Toulouse, France
Hospital
Valenciennes, France
Related Publications (2)
Futier E, De Jong A, Cirenei C, Godet T, Jabaudon M, Constantin JM, Grillot N, Bouzat P, Henry L, Margetis D, Lebuffe G, Garnier M, Lambert C, Pereira B, Jaber S; IMPROVE-2 Trial investigators. Personalized driving pressure-guided positive end-expiratory pressure in patients at risk of postoperative respiratory failure (IMPROVE-2): a multicenter, pragmatic, randomized clinical trial. Intensive Care Med. 2025 Oct;51(10):1797-1808. doi: 10.1007/s00134-025-08082-x. Epub 2025 Aug 21.
PMID: 40839096RESULTKhaled L, Godet T, Jaber S, Chanques G, Asehnoune K, Bourdier J, Araujo L, Futier E, Pereira B. Intraoperative protective mechanical ventilation in patients requiring emergency abdominal surgery: the multicentre prospective randomised IMPROVE-2 study protocol. BMJ Open. 2022 May 6;12(5):e054823. doi: 10.1136/bmjopen-2021-054823.
PMID: 35523498DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuel Futier
CHU de Clermont-Ferrand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- It will not be possible to mask the assigned ventilation strategy from the treating clinicians because they have an ethical responsibility to ensure patient safety during the emergency procedures. However, procedures will be put in place to minimize the possibility of bias arising because research staff becomes aware of trial group allocation. At each participating center, patients will be followed up for primary and secondary endpoints by members of the research staff who will be unaware of the trial group allocation. Information on whether the primary and secondary outcomes occur will be collected and entered into the electronic web-based case report form (eCRF) by trial or clinical trained personal (clinical research associate), blinded to the allocation group, under the supervision of the local principal investigator (PI) or designee who will also be unaware of the trial group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2019
First Posted
June 17, 2019
Study Start
February 18, 2021
Primary Completion
July 29, 2022
Study Completion
October 27, 2022
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 6 months following article publication. No end date
- Access Criteria
- . Data can be obtained upon request from the IMPROVE-2 steering committee. Readers may contact: efutier@chu-clermontferrand.fr to request the data.
The French National Data Safety Authority (CNIL) forbids making data freely available without prior agreement. Thus, the data underlying study findings cannot be made freely available because of ethical and legal restrictions. However, individual participant data underlying the results reported in the manuscript (text, tables, figures, and appendices) can be obtained after deidentification. Data can be obtained upon request from the IMPROVE-2 steering committee. Readers may contact: efutier@chu-clermontferrand.fr to request the data. The data cannot be freely available for the reasons mentioned above. Data access can be only possible after scientific assessment and data sharing agreement, detailing the type of data requested. This data sharing agreement has to be signed between applicants and the sponsor, Clermont-Ferrand University Hospital.